Biotechnology companies and researchers are studying treatments that could help patients with spinal-cord injuries recover abilities to move and function that they have lost. Each year about 18,000 Americans suffer spinal-cord injuries, which are often caused by automobile accidents, falls, violence and sports injuries, according to the National Spinal Cord Injury Statistical Center. Depending on […]

Cartesian Therapeutics, a biopharmaceutical company that specializes in mRNA-engineered cell therapy, recently announced the start of a Phase 2a clinical trial of its mRNA chimeric antigen receptor (CAR) T-cell therapy, Descartes-11, in patients with newly diagnosed, high-risk multiple myeloma. DocWire News spoke with Murat Kalayoglu, MD, PhD, President and Chief Executive Officer at Cartesian Therapeutics, […]

Oliver hosts Erez Raphael, the CEO of the global digital therapeutics company DarioHealth (DRIO) to discuss recent 4Q earnings results and the firm’s outlook going forward.